{
    "clinical_study": {
        "@rank": "100764", 
        "acronym": "First-HD", 
        "arm_group": [
            {
                "arm_group_label": "SD-809 ER Tablets", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "SD-809 Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether SD-809 ER tablets are effective in the\n      treatment of chorea associated with Huntington's Disease."
        }, 
        "brief_title": "First Time Use of SD-809 in Huntington Disease", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Chorea", 
        "condition_browse": {
            "mesh_term": [
                "Chorea", 
                "Huntington Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a randomized, double blind, placebo controlled, parallel group study designed to\n      evaluate the efficacy, safety and tolerability of SD-809 ER for the treatment of chorea\n      associated with Huntington's Disease.  Approximately 90 subjects will be randomized (1:1)\n      into the study, with approximately 45 subjects receiving SD-809 ER and 45 subjects receiving\n      placebo.  The study will be conducted at approximately 30 centers in the U.S. and Canada."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is at least 18 years of age or the age of majority (whichever is older) at\n             Screening.\n\n          2. Subject has been diagnosed with manifest HD, as indicated by characteristic motor\n             exam features and has a documented expanded CAG repeat (\u2265 37) at or before Screening.\n\n          3. Subject has a Total Maximal Chorea Score (TMC) \u2265 8 at Screening and Baseline.\n\n          4. Subject has a Total Functional Capacity (TFC) score \u2265 5 at Screening.\n\n          5. Subject is able to swallow study medication whole.\n\n          6. Subject has provided written, informed consent or, a legally authorized\n             representative (LAR) has provided written informed consent and the subject has\n             provided assent.\n\n          7. Female subjects of childbearing potential  agree to use an acceptable method of\n             contraception from screening through study completion.\n\n          8. The subject has a reliable caregiver who interacts with the patient on a daily basis,\n             oversees study drug administration, assures attendance at study visits and\n             participates in evaluations, as required.\n\n          9. Subject is able to ambulate without assistance for at least 20 yards (Note: The use\n             of assistive devices (i.e., walker, cane) is permitted during ambulation).\n\n        Exclusion Criteria:\n\n          1. Subject has a serious untreated or under-treated psychiatric illness, such as\n             depression, at Screening or Baseline.\n\n          2. Subject has active suicidal ideation at Screening or Baseline.\n\n          3. Subject has history of suicidal behavior at Screening or Baseline:\n\n          4. Subject has evidence for depression at Screening or Baseline.\n\n          5. Subject has an unstable or serious medical or psychiatric illness at Screening or\n             Baseline.\n\n          6. Subject has been recently exposed to tetrabenazine.\n\n          7. Subject has received any of the following concomitant medications within 30 days of\n             Screening or Baseline:\n\n               -  Antipsychotics\n\n               -  Metoclopramide\n\n               -  Monoamine oxidase inhibitors (MAOI)\n\n               -  Levodopa or dopamine agonists\n\n               -  Reserpine\n\n               -  Amantadine\n\n               -  Memantine\n\n          8. Subject has significantly impaired swallowing function at Screening.\n\n          9. Subject has significantly impaired speaking at Screening.\n\n         10. Subject requires treatment with drugs known to prolong the QT interval.\n\n         11. Subject has a prolonged QT interval on 12-lead ECG at Screening.\n\n         12. Subject has evidence of hepatic impairment at Screening.\n\n         13. Subject has evidence of significant renal impairment at Screening.\n\n         14. Subject has known allergy to any of the components of study medication.\n\n         15. Subject has participated in an investigational drug or device trial within 30 days\n             (or 5 drug half-lives) of Screening, whichever is longer.\n\n         16. Subject is pregnant or breast-feeding at Screening or Baseline.\n\n         17. Subject acknowledges present use of illicit drugs at Screening.\n\n         18. Subject has a history of alcohol or substance abuse in the previous 12 months."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01795859", 
            "org_study_id": "SD-809-C-15"
        }, 
        "intervention": [
            {
                "arm_group_label": "SD-809 ER Tablets", 
                "description": "SD-809 tablets are available in three dose strengths:  6, 9 and 12 mg, all of which are identical in size, shape and color (white).", 
                "intervention_name": "SD-809", 
                "intervention_type": "Drug", 
                "other_name": "dutetrabenazine"
            }, 
            {
                "arm_group_label": "SD-809 Placebo", 
                "description": "Placebo tablets are identical in appearance to SD-809 tablets.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Huntington disease", 
            "Chorea", 
            "Tetrabenazine"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35233"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fayetteville", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72703"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Englewood", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80113"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32607"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33136"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30329"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iowa City", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52242"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "66160"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67226"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89102"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Camden", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08103"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Brunswick", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08901"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "12208"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27705"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43210"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84108"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kirkland", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98034"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98195"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M2K 1E1"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montreal", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H2L 4M1"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Double Blind, Placebo Controlled Study of SD-809 Extended Release for the Treatment of Chorea Associated With Huntington Disease", 
        "overall_contact": {
            "email": "info@hsglimited.org", 
            "last_name": "Huntington Study Group (HSG)", 
            "phone": "800-487-7671"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Total Maximal Chorea Score (TMC)", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01795859"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Treatment Success at the end of therapy as measured by the Patient Global Impression of Change (PGIC)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Treatment success at the end of therapy based on Clinical Global Impression of Change (CGIC)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change in Short Form 36 Health Survey (SF-36) Physical component summary score", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change in Berg Balance Test (BBT)", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Auspex Pharmaceuticals, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Auspex Pharmaceuticals, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}